Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danai Dima

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Neuroimage. Clinical|December 31, 2021
Choroid plexus enlargement is associated with neuroinflammation and reduction of blood brain barrier permeability in depressionNoha Althubaity, Julia Schubert, Daniel Martins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
BIO26-048: A Meta-Analytic Evaluation of Efficacy and Safety Between Ide-cel and Cilta-cel in Relapsed/Refractory Multiple Myeloma Based on Clinical Trial and Real-World DataMobina Golmohammadi, Shahzad Raza, Doris K Hansen, et al.
Scientific Reports|November 9, 2017
Development of multivariable models to predict change in Body Mass Index within a clinical trial population of psychotic individualsRebecca N S Harrison, Fiona Gaughran, Robin M Murray, et al.
International Journal of Molecular Sciences|June 19, 2024
Current Novel Targeted Therapeutic Strategies in Multiple MyelomaCindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
Journal of Clinical Medicine|February 26, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory AnalysisBruno Almeida Costa, Danai Dima, Tomer Mark, et al.
Schizophrenia Bulletin|April 20, 2018
Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity StudyJosé M Goikolea, Danai Dima, Ramón Landín-Romero, et al.
Psychiatry Research|May 23, 2013
Childhood abuse is associated with structural impairment in the ventrolateral prefrontal cortex and aggressiveness in patients with borderline personality disorderNiccolò Morandotti, Danai Dima, Jigar Jogia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 3, 2024
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapyDanai Dima, Michael Hughes, Mark Orland, et al.
British Journal of Haematology|January 24, 2024
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre studyDanai Dima, Aliya Rashid, James A Davis, et al.
British Journal of Haematology|October 24, 2025
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomesDaniel Cancilla, Hanny Sawaf, Xuefei Jia, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Neuroimage. Clinical|December 31, 2021
Choroid plexus enlargement is associated with neuroinflammation and reduction of blood brain barrier permeability in depressionNoha Althubaity, Julia Schubert, Daniel Martins, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
BIO26-048: A Meta-Analytic Evaluation of Efficacy and Safety Between Ide-cel and Cilta-cel in Relapsed/Refractory Multiple Myeloma Based on Clinical Trial and Real-World DataMobina Golmohammadi, Shahzad Raza, Doris K Hansen, et al.
Scientific Reports|November 9, 2017
Development of multivariable models to predict change in Body Mass Index within a clinical trial population of psychotic individualsRebecca N S Harrison, Fiona Gaughran, Robin M Murray, et al.
International Journal of Molecular Sciences|June 19, 2024
Current Novel Targeted Therapeutic Strategies in Multiple MyelomaCindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
Journal of Clinical Medicine|February 26, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory AnalysisBruno Almeida Costa, Danai Dima, Tomer Mark, et al.
Schizophrenia Bulletin|April 20, 2018
Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity StudyJosé M Goikolea, Danai Dima, Ramón Landín-Romero, et al.
Psychiatry Research|May 23, 2013
Childhood abuse is associated with structural impairment in the ventrolateral prefrontal cortex and aggressiveness in patients with borderline personality disorderNiccolò Morandotti, Danai Dima, Jigar Jogia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 3, 2024
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapyDanai Dima, Michael Hughes, Mark Orland, et al.
British Journal of Haematology|January 24, 2024
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre studyDanai Dima, Aliya Rashid, James A Davis, et al.
British Journal of Haematology|October 24, 2025
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomesDaniel Cancilla, Hanny Sawaf, Xuefei Jia, et al.
Pageof 17